NeoGenomics price target raised to $21 from $19 at TD Cowen

TD Cowen raised the firm’s price target on NeoGenomics to $21 from $19 and keeps an Outperform rating on the shares. The firm said the company’s volumes/price were key drivers and the mix shift are central to the shares’s thesis. As well, the company raised the long-term sales growth guide so all in, a solid update.